Nora A. Janjan

Texas A&M Health Science Center — United States

Medicine · Health Sciences

70h-index16.5kcitations316works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal and Anal Carcinomas(68), Colorectal Cancer Surgical Treatments(57), Management of metastatic bone disease(42), Pancreatic and Hepatic Oncology Research(34), Advanced Radiotherapy Techniques(29)

Publications313 total

Alternative evidence in drug development and regulatory science
Elsevier eBooks·2023· 1 cited
Plain Language Summary: Does the Amount of Time it Takes for Prostate-Specific Antigen to Double Affect How Long Men with Nonmetastatic Castration-Resistant Prostate Cancer Live and their Healthcare Costs?
Future Oncology·2023Open Access
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations
Frontiers in Medicine·2023· 8 citedOpen Access
Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer·2023· 5 citedOpen Access
Does Race Make a Difference in how Long Men with Advanced Prostate Cancer Live when Treated with Abiraterone or Enzalutamide?
Future Oncology·2022Open Access
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017
The Oncologist·2022· 76 citedOpen Access
Clinical and economic burden of HPV-related cancers in the US veteran population
Journal of Medical Economics·2022· 14 citedOpen Access
COVID‐19 associated disruptions in routine health care of people with mild cognitive impairment or dementia
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2022· 14 citedOpen Access
Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases·2021· 30 citedOpen Access
Retrospective real-world comparison of clinical and economic burden between first-generation and second-generation tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML).
Journal of Clinical Oncology·2021
Spectacular Progress in Lung Cancer Care
ONCOLOGY·2021· 2 citedOpen Access
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis
Journal of Managed Care & Specialty Pharmacy·2020· 12 citedOpen Access
PRO20 ASSESSMENT OF ECONOMIC BURDEN AND HOSPITALIZATION ON PATIENTS WITH HAIRY CELL LEUKEMIA IN THE US VETERANS HEALTH ADMINISTRATION POPULATION
Value in Health·2020
Overall survival (OS) in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving bicalutamide (BIC) followed by enzalutamide (ENZA) or abiraterone (ABI).
Journal of Clinical Oncology·2020
Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical Management
Neuromodulation Technology at the Neural Interface·2016· 34 citedOpen Access
Assumption of risk, healthcare policy, and cancer screening.
PubMed·2014
Health services utilization and payments in patients with cancer pain: A comparison of intrathecal drug delivery versus conventional medical management.
Journal of Clinical Oncology·2014
Improving Cancer Pain Control With NCCN Guideline-Based Analgesic Administration: A Patient-Centered Outcome
Journal of the National Comprehensive Cancer Network·2014· 23 cited
The risks of undiagnosed cancer vs the theoretical risks of radiation exposure.
PubMed·2014
MEDICAL COMMITTEE of the TEXAS RADIATION ADVISORY BOARD MEETING AGENDA AUSTIN-Health and Human Services Commission, MHMR Center
2014
page 1 of 16Next →

Frequent Co-authors

Christopher H. Crane(18), John M. Skibber(15), Robert A. Wolff(14), Barry W. Feig(13), Marc E. Delclos(12), James L. Abbruzzese(11), Peter W. T. Pisters(9), Karen R. Cleary(8), Prajnan Das(8), Miguel A. Rodrı́guez-Bigas(8), Jean‐Nicolas Vauthey(8), Douglas B. Evans(7), Cathy Eng(7), Patrick M. Lynch(6), Jaffer A. Ajani(6), Renato Lenzi(6), Charles S. Cleeland(5), Tyvin A. Rich(5), George J. Chang(5), Lee M. Ellis(5)